Moderna Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (2010)
Status: Acquired by Indevus Pharmaceuticals (2006) → now Bristol-Myers Squibb (2001)

Organization Overview

First Clinical Trial
2015
NCT03076385
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Moderna Therapeutics | ModernaTX, Inc. | Valera Pharmaceuticals